Gennao Bio Closes $40 Million Series A Financing to Develop Pipeline of Targeted Nucleic Acid Therapeutics

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2R2MLDs
via IFTTT